Eli Lilly
LLY
$7.80 (-1.00%)
1D
1W
3M
1Y
5Y
ALL
Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Reuters • 1 day ago • LLY
Demand for obesity drugs shoots up in India as Lilly, Novo jostle for market shareBusiness Insider • 1 day ago • LLY
Eli Lilly's 3-step strategy to dominate the $95 billion obesity marketThe Motley Fool • 1 day ago • LLY
Better Growth Buy: Eli Lilly vs. Viking TherapeuticsThe Motley Fool • 2 days ago • LLY
2 Dividend Growth Stocks to Buy and Hold ForeverBarrons • 4 days ago • LLY
Lilly and Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns.Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.